Marshall Wace’s HUTCHMED HCM Stock Holding History

Marshall Wace’s Portfolio HCM Stock Details HCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-14,897	Closed	-$235K	–	3163
2025 Q3	$235K	Sell	14,897 -4,985	-25%	-$82K	﹤0.01%	2525
2025 Q2	$299K	Buy	19,882 +254	+1%	+$3.71K	﹤0.01%	2324
2025 Q1	$295K	Buy	19,628 +1,526	+8%	+$22.6K	﹤0.01%	2275
2024 Q4	$261K	Buy	+18,102	New	+$323K	﹤0.01%	2277
2024 Q1	–	Sell	-16,900	Closed	-$306K	–	2590
2023 Q4	$306K	Buy	16,900 +1,500	+10%	+$27.3K	﹤0.01%	1884
2023 Q3	$261K	Sell	15,400 -25,570	-62%	-$366K	﹤0.01%	1923
2023 Q2	$492K	Buy	40,970 +16,907	+70%	+$231K	﹤0.01%	1996
2023 Q1	$313K	Buy	+24,063	New	+$394K	﹤0.01%	2283
2021 Q2	–	Sell	-38,508	Closed	-$1.09M	–	2807
2021 Q1	$1.09M	Buy	+38,508	New	+$1.23M	0.01%	1618
2019 Q4	–	Sell	-10,261	Closed	-$183K	–	1850
2019 Q3	$183K	Buy	+10,261	New	+$214K	﹤0.01%	1297
2016 Q2	–	Sell	-70,314	Closed	-$928K	–	1053
2016 Q1	$928K	Buy	+70,314	New	+$941K	0.01%	734

Other funds holding HCM

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIA Group Hong Kong $6.88B AUM 20.97% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

XY Capital Central, Hong Kong $101M AUM 1.14% 1-Year Est. Return

Marshall Wace's HCM Position: Q4 2025 in Review

Marshall Wace sold out of HUTCHMED (HCM) in Q4 2025, closing a stake of 14,897 shares — an estimated $235K sold.

Marshall Wace first reported a position in HCM in Q1 2016 and held it in 11 quarters. The position peaked at $1.09M in Q1 2021. 50 funds tracked by Wall St. Rank hold HCM as of Q4 2025.

Marshall Wace reported no remaining HUTCHMED position as of Q4 2025 after selling out during the quarter.
Marshall Wace sold 14,897 HUTCHMED shares in Q4 2025, an estimated $235K.
Marshall Wace first reported a position in HUTCHMED in Q1 2016 and held it in 11 quarters.
Marshall Wace's HUTCHMED position peaked at $1.09M in Q1 2021.
50 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2025.

Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.